Our results suggest that in ERMS cells p16-related epigenetic modification could be carried out by DNMT3A, since we did not detect increased p16 expression levels after si-DNMT3B transfection. This evidence concerns the gene DNMT3B and embryonal rhabdomyosarcoma.